Ignite Creation Date:
2025-12-24 @ 11:07 PM
Ignite Modification Date:
2026-01-01 @ 11:07 AM
Study NCT ID:
NCT05413369
Status:
COMPLETED
Last Update Posted:
2025-09-24
First Post:
2022-06-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
iGlarLixi vs IDegAsp in Chinese Participants After OAD(s)
Sponsor:
Sanofi
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-07-07
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-10-20
Completion Date Type:
ACTUAL
First Submit Date:
2022-06-07
First Submit QC Date:
None
Study First Post Date:
2022-06-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-10-08
Results First Submit QC Date:
None
Results First Post Date:
2024-10-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-21
Last Update Post Date:
2025-09-24
Last Update Post Date Type:
ESTIMATED